Plants as sources of natural and recombinant anti-cancer agents
JF Buyel - Biotechnology advances, 2018 - Elsevier
Herbal remedies were the first medicines used by humans due to the many
pharmacologically active secondary metabolites produced by plants. Some of these …
pharmacologically active secondary metabolites produced by plants. Some of these …
Plant-based production of biopharmaceuticals
Plants are now gaining widespread acceptance as a general platform for the large-scale
production of recombinant proteins. The first plant-derived recombinant pharmaceutical …
production of recombinant proteins. The first plant-derived recombinant pharmaceutical …
Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
2010-04-30 Assigned to REACTIVE SURFACES, LTD. reassignment REACTIVE
SURFACES, LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
SURFACES, LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
Plant molecular farming: systems and products
Plant molecular farming is a new and promising industry involving plant biotechnology. In
this review, we describe several diverse plant systems that have been developed to produce …
this review, we describe several diverse plant systems that have been developed to produce …
Recovery and purification of plant-made recombinant proteins
LR Wilken, ZL Nikolov - Biotechnology advances, 2012 - Elsevier
Plants are becoming commercially acceptable for recombinant protein production for human
therapeutics, vaccine antigens, industrial enzymes, and nutraceuticals. Recently, significant …
therapeutics, vaccine antigens, industrial enzymes, and nutraceuticals. Recently, significant …
Production of pharmaceutical‐grade recombinant aprotinin and a monoclonal antibody product using plant‐based transient expression systems
GP Pogue, F Vojdani, KE Palmer, E Hiatt… - Plant biotechnology …, 2010 - Wiley Online Library
Plants have been proposed as an attractive alternative for pharmaceutical protein
production to current mammalian or microbial cell‐based systems. Eukaryotic protein …
production to current mammalian or microbial cell‐based systems. Eukaryotic protein …
Extraction and downstream processing of plant-derived recombinant proteins
Plants offer the tantalizing prospect of low-cost automated manufacturing processes for
biopharmaceutical proteins, but several challenges must be addressed before such goals …
biopharmaceutical proteins, but several challenges must be addressed before such goals …
Biological active coating components, coatings, and coated surfaces
C McDaniel - US Patent App. 10/655,345, 2004 - Google Patents
C09D—COATING COMPOSITIONS, eg PAINTS, VARNISHES OR LACQUERS; FILLING
PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; …
PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; …
Microorganism coating components, coatings, and coated surfaces
C McDaniel - US Patent App. 10/792,516, 2004 - Google Patents
Disclosed herein are novel paints and coatings comprising a cell-based particulate material.
Specifically disclosed herein is cell-based particulate material prepared from …
Specifically disclosed herein is cell-based particulate material prepared from …
Commercial aspects of pharmaceutical protein production in plants
Many different plant-based systems have been used to produce recombinant
pharmaceutical proteins but only a small number have made the leap from an experimental …
pharmaceutical proteins but only a small number have made the leap from an experimental …